The present invention relates to the use of Coenzyme Q10 or functionally equivalent derivative thereof, through topical or systemic administration, for the prevention, the treatment and/or attenuation of degenerative ocular pathologies, said pathologies being of an heredofamilial, inflammatory, dysmetabolic, senile age-related nature, the degenerative process deriving from apoptotic events caused by hypoxia or other detrimental stimuli due to ischemia or to the lack of trophic factors.
Use of quinone Q10 for the treatment of ocular diseases / BRANCATO R; CAPACCIOLI S; LENAZ G; N. SCHIAVONE. - (2002).
Use of quinone Q10 for the treatment of ocular diseases.
BRANCATO, ROSARIO;CAPACCIOLI, SERGIO;SCHIAVONE, NICOLA
2002
Abstract
The present invention relates to the use of Coenzyme Q10 or functionally equivalent derivative thereof, through topical or systemic administration, for the prevention, the treatment and/or attenuation of degenerative ocular pathologies, said pathologies being of an heredofamilial, inflammatory, dysmetabolic, senile age-related nature, the degenerative process deriving from apoptotic events caused by hypoxia or other detrimental stimuli due to ischemia or to the lack of trophic factors.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
EP1321138B1(US7029672).pdf
accesso aperto
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Open Access
Dimensione
1.76 MB
Formato
Adobe PDF
|
1.76 MB | Adobe PDF | |
|
US7029672.pdf
accesso aperto
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Open Access
Dimensione
622.48 kB
Formato
Adobe PDF
|
622.48 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
